Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Certis Belchim is a global leader in the crop protection industry, established in 2022 through the merger of Certis Europe and Belchim Crop Protection. The company provides a comprehensive portfolio of both conventional chemical solutions and innovative biorationals, such as microbials, pheromones, and plant extracts. As a key subsidiary of Mitsui & Co., Certis Belchim focuses on sustainable agriculture and integrated pest management (IPM) to support modern farming needs. Its products are designed to protect high-value specialty crops and arable farming from a wide range of pests and diseases. The organization operates with a strong presence in Europe and North America, leveraging deep technical expertise and a robust regulatory pipeline. By integrating biological and chemical expertise, Certis Belchim helps growers achieve high yields while meeting stringent environmental and safety standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Certis Belchim.